Clincosm LogoSign in Get a demo

Spectrum of Epididymis and Vas Deferens Anomalies Among Children With Cryptorchidism

Sponsor
Aswan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04696874
Collaborator
(none)
22
Enrollment
1
Location
17.9
Actual Duration (Months)
1.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

: Data was collected retrospectively from six centers providing care for patients with undescended testicles from September 2017 to February 2019. All patients whose congenital anomalies of the epididymis or vas deferens were discovered incidentally during operative intervention for cryptorchidism and where photographs of the anomalies were taken were included.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Background: Epididymal and vas deferens anomalies are not rare among children with cryptorchidism. They may affect fertility following orchiopexy.

    Material and Methods: Data was collected retrospectively from six centers providing care for patients with undescended testicles from September 2017 to February 2019. All patients whose congenital anomalies of the epididymis or vas deferens were discovered incidentally during operative intervention for cryptorchidism and where photographs of the anomalies were taken were included.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    22 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Spectrum of Epididymis and Vas Deferens Anomalies Among Children With Cryptorchidism: A Retrospective Multi-center Study
    Actual Study Start Date :
    Sep 1, 2017
    Actual Primary Completion Date :
    Feb 28, 2019
    Actual Study Completion Date :
    Feb 28, 2019

    Outcome Measures

    Primary Outcome Measures

    1. collection of cases [one and half year]

      retrospective from multicenter university hospital

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Months to 125 Weeks
    Sexes Eligible for Study:
    Male
    Inclusion Criteria:
    • All included cases had photographic documentation.
    Exclusion Criteria:
    • cases without photographic documentation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sarah Magdy Abdelmohsen Cairo P.O.Pox. 11331 Egypt Haddaek El-K

    Sponsors and Collaborators

    • Aswan University Hospital

    Investigators

    • Principal Investigator: Sarah M Abdelmohsen, MD, Aswan University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Magdy, Principle investigator, Aswan University Hospital
    ClinicalTrials.gov Identifier:
    NCT04696874
    Other Study ID Numbers:
    • AswanUH1
    First Posted:
    Jan 6, 2021
    Last Update Posted:
    Jan 6, 2021
    Last Verified:
    Jan 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Magdy, Principle investigator, Aswan University Hospital
    epididymal cyst
    duplicated vas deferens.
    curled vas deferens
    vanished testis
    Additional relevant MeSH terms:
    Cryptorchidism
    Spermatocele
    Congenital Abnormalities

    Study Results

    No Results Posted as of Jan 6, 2021